US Patent 7335365 HIV-encoded chemoattractant
Patent 7335365 was granted and assigned to University of Iowa on February, 2008 by the United States Patent and Trademark Office.
All edits
The combination of HIV proteins Tat and Nef is chemotactic for CD4+ cells. Utilizing the capacity of Tat and Nef to modulate CD4+ cell trafficking and infiltration, the invention provides various treatment modes for individuals infected with HIV. The invention further provides treatment modes for other localized diseases by controlling CD4+ cell trafficking and infiltration. In particular, the invention provides methodology for promoting CD4+ cell chemotaxis to a localized site of infection as a means of augmenting the efficacy of extant chemotherapeutic methods. The invention further provides methodology for diverting CD4+ cell infiltration from a localized site where the presence of CD4+ cells is detrimental to the clinical outcome, by providing a composition comprising Tat and Nef at a distinct site, such as blood, within the individual where the accumulation of CD4+ cells is less detrimental.
US Patent 07335365 HIV-encoded chemoattractant US Patent 7335365 HIV-encoded chemoattractant
US Patent 07335365 HIV-encoded chemoattractant
Find more entities like US Patent 7335365 HIV-encoded chemoattractant
